Speaker illustration

Mr Jooyoung Woo

Busan (Korea (Republic of))

Validation of CHA2DS2-VA score (excluding female sex) in non-valvular atrial fibrillation patients: a nationwide population-based study

Event: ESC Congress 2019

Topic: Stroke Prevention

Session: Epidemiology of atrial fibrillation

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb